Bdmedicines.com is a popular medicinal website in Bangladesh.

A Market Analysis for Anti-diabetic Products


Diabetes is a chronic disease in which there are high levels of sugar in the blood. The World Diabetes Foundation estimates that there will be 438 million people with diabetes by the year 2030. Oral anti-diabetics were the leading category of drugs in 2014 and showed a growth rate of 6.3% from the total global sales. The total sales for insulin products increased significantly as well.

Anti-diabetic products include glucose meters, lancets, test strips, continuous blood glucose meters, insulin, insulin pumps, syringes and other insulin delivery devices and anti-diabetic drugs. The bulk of product revenues come from three segments - test strips, insulin and anti-diabetic drugs - which will remain the largest sources of product revenues over the next ten years. The most significant growth, however, will come from the nascent segment of continuous blood glucose monitors, which provide significantly added clinical benefit at only a modestly higher cost compared to standard blood glucose meters.

Top players in the global diabetes market are Novo Nordisk, Eli Lilly, Merck & Co., amongst others. Significant R&D has been observed in the pre-insulin market leading to the development of several novel and safer therapies. The comparative performance of these therapies, such as the DPP-IV inhibitors and GLP-1 analogs is expected to shape the diabetes market landscape in the long term.

With the rapid advances in technology, it is no wonder that there are now many novel emerging drug classes available for the treatment of diabetes.

An analysis of the diabetes market in India and China, two of the countries with the largest prevalence of diabetes, is also included, along with a look at industry research and development.

Bangladesh is one of the 6 countries of the IDF SEA region. 415 million people have diabetes in the world and 78 million people in the SEA Region; by 2040 this will rise to 140 million. There were 7.1 million cases of diabetes in Bangladesh in 2015

So anti diabetic products are getting large market space in Bangladesh. Most of the pharmaceutical companies are going to more concentrate for producing anti diabetic products in Bangladesh. Leading pharmaceutical companies already start to produce insulin based products with other drugs.

So it's a great scope for pharmaceutical companies in Bangladesh to grow-up their market size with producing a large number of anti diabetic drugs.

0 comments:

Post a Comment

Note: Only a member of this blog may post a comment.